Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models

BACKGROUND: Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. Histone deacetylase (HDAC) inhibitors have been reported to have antitumor activity in different malignancies and immunomodulatory effects. Herein, we report the Tregs-targeting and immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Li, Ciesielski, Michael, Ramakrishnan, Swathi, Miles, Kiersten M., Ellis, Leigh, Sotomayor, Paula, Shrikant, Protul, Fenstermaker, Robert, Pili, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267747/
https://www.ncbi.nlm.nih.gov/pubmed/22303460
http://dx.doi.org/10.1371/journal.pone.0030815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267747/
https://www.ncbi.nlm.nih.gov/pubmed/22303460
http://dx.doi.org/10.1371/journal.pone.0030815

Ejemplares similares